Calysta Energy is developing new biological gas-to-liquids and biological gas-to-chemicals technologies using methane, the primary component of natural gas. The technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels with cost and performance advantages over current processes. Calysta is focusing on development of methane as a new biological feedstock for cost-competitive, scalable biofuels and chemicals production. Methane is widely available from large domestic deposits of shale gas, as well as landfills and other sources. Calysta\'s natural gas conversion technologies use proprietary organisms to economically convert methane into liquid hydrocarbons, the building blocks of higher-value, easily transportable fuels and chemicals.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/13/13 | $3,000,000 | Series A |
Pangaea Ventures | undisclosed |
| 01/22/15 | $10,000,000 | Series B |
Aqua-Spark Pangaea Ventures Walden-Riverwood Ventures | undisclosed |
| 05/02/17 | $40,000,000 | Series D |
Aqua-Spark Cargill Mitsui & Co  Municipal Employee Retirement System of Michigan Pangaea Ventures Temasek Walden-Riverwood Ventures | undisclosed |
| 06/27/19 | $30,000,000 | Venture |
BP Ventures | undisclosed |
